ROIVRoivant Sciences Ltd.

$36.49+113% 1Y

Is the price fair?

What ROIV's price assumes

Price / book
6.03

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
6.03
EV / EBIToperating margin −7915%: the multiple describes the denominator
not meaningful
Market capitalisation722.3 million shares, counted Jul 31, 2026
$26.4B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.